slides · global inventory
List
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 110,539
Current window 86,761-86,790
Pages 3,685
Rows per page 30
Component
86,761-86,790 of 110,539
16
Includes detailed financial table comparing 4Q22, 3Q22, 4Q21, 2022, and 2021 metrics.Credit Suisse | Results Presentation Deck | 44 slides · Credit Suisse
Deck Investor relations Beat · Satisfaction1 hit
17
The slide uses a structured table format with vertical labels for business segments (Revenues, PCL/Costs, Profitability, AuM, Balance Sheet, RMs).Credit Suisse | Results Presentation Deck | 44 slides · Credit Suisse
Deck Investor relations Beat · Satisfaction1 hit
18
Includes a detailed financial table comparing quarterly and annual results, alongside key commentary on performance drivers.Credit Suisse | Results Presentation Deck | 44 slides · Credit Suisse
Deck Investor relations Beat · Satisfaction1 hit
19
Includes detailed table of financial metrics (Revenues, PCL/Costs, Profitability, Balance Sheet) and qualitative commentary on drivers.Credit Suisse | Results Presentation Deck | 44 slides · Credit Suisse
Deck Investor relations Beat · Satisfaction1 hit
20
Financial performance slide showing capital and RWA movements.Credit Suisse | Results Presentation Deck | 44 slides · Credit Suisse
Deck Investor relations Beat · Satisfaction1 hit
24
The slide uses a stacked bar chart to compare issuance vs redemption volumes, with a specific focus on the 2023 full-year plan.Credit Suisse | Results Presentation Deck | 44 slides · Credit Suisse
Deck Investor relations Beat · ActionLoop · Quick Win Big Bet1 hit
25
Includes a waterfall-style bar chart for revenue sensitivity and a line chart showing yield curve shifts.Credit Suisse | Results Presentation Deck | 44 slides · Credit Suisse
Deck Investor relations Beat · ActionLoop · Quick Win Big Bet1 hit
03
Crocs | Investor Presentation Deck | 47 slidesCrocs | Investor Presentation Deck | 47 slides · Crocs
Pitch deck Investor relations Beat · Problem1 hit
05
The slide uses a grid layout to present six distinct corporate values.Crocs | Investor Presentation Deck | 47 slides · Crocs
Pitch deck Investor relations Beat · Problem1 hit
06
The slide uses a four-stage chronological framework to illustrate corporate turnaround and strategic focus.Crocs | Investor Presentation Deck | 47 slides · Crocs
Pitch deck Investor relations Beat · Solution1 hit
16
The slide uses a mix of bulleted strategic points and lifestyle imagery to justify the sandal category as a growth driver.Crocs | Investor Presentation Deck | 47 slides · Crocs
Pitch deck Investor relations Beat · Market SizeLoop · Cost Of Inaction1 hit
17
The slide uses a 'Growth Drivers' section header and a simple bar chart to visualize the 29% growth projection.Crocs | Investor Presentation Deck | 47 slides · Crocs
Pitch deck Investor relations Beat · Market SizeLoop · Cost Of Inaction1 hit
21
The slide highlights growth, organizational scaling, supply chain, and marketing investment.Crocs | Investor Presentation Deck | 47 slides · Crocs
Pitch deck Investor relations Beat · Market SizeLoop · Cost Of Inaction1 hit
23
Includes a collage of brand collaborations (Salehe Bembury, Luke Combs, SZA, Jimmy Kimmel).Crocs | Investor Presentation Deck | 47 slides · Crocs
Pitch deck Investor relations Beat · FinancialsLoop · Quick Win Big Bet1 hit
26
Includes brand performance metrics and marketing highlights.Crocs | Investor Presentation Deck | 47 slides · Crocs
Pitch deck Investor relations Beat · FinancialsLoop · Quick Win Big Bet1 hit
29
Includes brand performance metrics and financial KPIs for Q4 2022.Crocs | Investor Presentation Deck | 47 slides · Crocs
Pitch deck Investor relations Beat · FinancialsLoop · Quick Win Big Bet1 hit
30
Includes footnotes regarding non-GAAP adjustments.Crocs | Investor Presentation Deck | 47 slides · Crocs
Pitch deck Investor relations Beat · FinancialsLoop · Quick Win Big Bet1 hit
11
The slide uses a two-tier layout to distinguish between Phase 1 and Preclinical development stages.Dare Bioscience | Investor Presentation Deck | 54 slides · Daré Bioscience
Pitch deck Investor relations 1 hit
12
The slide uses a process-like flow to connect internal strengths to external market validation.Dare Bioscience | Investor Presentation Deck | 54 slides · Daré Bioscience
Pitch deck Investor relations 1 hit
13
The slide uses a standard team/board layout with a logo cloud at the bottom to establish credibility.Dare Bioscience | Investor Presentation Deck | 54 slides · Daré Bioscience
Pitch deck Investor relations Beat · Team1 hit
15
The slide uses a simple list format to communicate upcoming program milestones.Dare Bioscience | Investor Presentation Deck | 54 slides · Daré Bioscience
Pitch deck Investor relations 1 hit
20
Standard pharmaceutical ISI (Important Safety Information) slide.Dare Bioscience | Investor Presentation Deck | 54 slides · Daré Bioscience
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
27
Includes details on milestone payments, royalties, and strategic support from Bayer.Dare Bioscience | Investor Presentation Deck | 54 slides · Daré Bioscience
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
28
Includes a testimonial quote from a Bayer executive.Dare Bioscience | Investor Presentation Deck | 54 slides · Daré Bioscience
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
32
The slide uses a double-bordered box design to separate academic meta-analysis from commercial market research estimates.Dare Bioscience | Investor Presentation Deck | 54 slides · Daré Bioscience
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
33
The slide uses a light blue callout box to group the product benefits and highlights the lack of current FDA-approved treatments for FSAD.Dare Bioscience | Investor Presentation Deck | 54 slides · Daré Bioscience
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
34
The slide outlines the methodology and goals of a clinical trial, specifically mentioning the RESPOND study.Dare Bioscience | Investor Presentation Deck | 54 slides · Daré Bioscience
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
35
The slide uses clinical trial data to justify the pivot to a topical delivery mechanism.Dare Bioscience | Investor Presentation Deck | 54 slides · Daré Bioscience
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
37
Study design is a small N=6 crossover trial.Dare Bioscience | Investor Presentation Deck | 54 slides · Daré Bioscience
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
44
The slide uses a grid-based layout to organize product candidates by development stage (Phase 1 vs Preclinical).Dare Bioscience | Investor Presentation Deck | 54 slides · Daré Bioscience
Pitch deck Investor relations Loop · Cost Of Inaction1 hit